Vistagen Therapeutics (VTGN) Revenue (2010 - 2026)
Vistagen Therapeutics' Revenue was $138,000 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 46.5% from $258,000 a year earlier and down 90.7% from the prior quarter.
Vistagen Therapeutics (VTGN) Revenue (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vistagen Therapeutics' Revenue was $2.38 million through Sep 30, 2026, up 230.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $1.27 million, up 161.1% from FY2025.
- Revenue shows a five-year compound annual growth rate of 3.1% (FY2021 to FY2026).
- In earlier fiscal years, Revenue was $486,000 in FY2025 (-54.3%), $1.06 million in FY2024 (+368.7%), $227,000 in FY2023 (-79.5%) and $1.11 million in FY2022 (+1.8%).
- The fiscal Q2 2027 figure marks the lowest quarterly Revenue since fiscal Q4 2025.
- Compared with a year earlier, Revenue was higher in four of the last six quarters, with growth averaging 112.7%.
- The best year-over-year quarter for Revenue over five years was fiscal Q1 2027 (growth of 504.9%); the worst was fiscal Q4 2022 (a decline of 91.2%).
- Per Business Quant data, VTGN's Revenue in the three fiscal quarters before Q2 2027 was $1.48 million (Q1 2027), $465,000 (Q4 2026) and $303,000 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 212,806.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 24.40 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 25.40 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 17.40 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 18.09 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | 138,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 138,000.00 |
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | 465,000.00 |
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 258,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Jun 30, 2024 | 84,000.00 |
| Mar 31, 2024 | 164,000.00 |
| Dec 31, 2023 | 411,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 176,000.00 |
| Dec 31, 2022 | 180,000.00 |
| Sep 30, 2022 | 893,000.00 |
| Jun 30, 2022 | 310,100.00 |
| Mar 31, 2022 | 39,000.00 |
| Dec 31, 2021 | 358,000.00 |
Vistagen Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();